Companion Animal Vaccines Have Witnessed Robust Demand With Pet Owners Becoming Increasing Aware Of Animal Healthcare

It is widely accepted that companion animal vaccines have saved countless lives over the years. All companion animal vaccines work by stimulating the body's natural immune system to fight off the infection similar to human vaccines. Like the human version of this process, the animal's immune system will develop antibodies to attack the pathogen that causes the disease. The dead virus then becomes stuck in the pet's body; without it, the infection cannot be spread to others. Once the immunity has developed, the antibodies will continue to fight off the illness, preventing it from spreading to other animals.

For years, researchers have been attempting to improve the effectiveness of companion animal vaccines. Due to this, some researchers have made a breakthrough with the development of live viral large cell virus (VLCV) vaccine production. Although this technology has been around for years, it was not until recently that it was used in the context of companion animal vaccines. The live virus is delivered to the cat or dog via a nasal spray, injection, or oral tablet. Once inside the animal's body, it forces the cat or dog to begin producing antibodies to attack the virus. Although the animals can naturally produce this antibody, producing it for the first time during a vaccine production process speeds up the process. In turn, this acceleration of the process helps to boost the effectiveness of the vaccine.

While it is very important to use the best possible vaccines for pets, there are times when an animal is not able to receive the necessary doses. Viral infections such as poliovirus, distemper, and rabies, as well as infections caused by bacteria such as Lassa, Escherichia, and Mumps, are examples of viruses that do not respond to traditional animal vaccination methods. These viruses often attack cellular tissues and lead to severe health problems. Recently, in March 2021, Russia launched the world’s first coronavirus vaccine Canivak-Cov for dogs, cats, and other animals. The vaccine is developed by scientists at the Federal Service for Veterinary and Phytosanitary Surveillance.